Abafungin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Template:Cs1 config Template:Drugbox

Abafungin (INN) is a broad-spectrum arylguanidines-class antifungal agent with a novel mechanism of action for the treatment of dermatomycoses.[1]

Abasol is a topical cream formulation of abafungin by York Pharma.[2]

History

Abafungin was first synthesized at Bayer AG, Leverkusen, Germany. A study of H2-antagonists related to famotidine, resulted in the discovery of its antifungal properties.[3]

Its development seems to have been discontinued in 2009.[4]

Mechanism of action

Unlike imidazole- and triazole-class antifungals, abafungin directly impairs the fungal cell membrane.[3]

In addition, abafungin inhibits the enzyme sterol 24-C-methyltransferase, modifying the composition of the fungal membrane.[5]

Abafungin has antibiotic activity against gram-positive bacteria as well as sporicidal activity.[6]

References

<templatestyles src="Reflist/styles.css" />

  1. Script error: No such module "Citation/CS1".
  2. Script error: No such module "citation/CS1".
  3. a b Script error: No such module "Citation/CS1".
  4. Script error: No such module "citation/CS1".
  5. Script error: No such module "Citation/CS1".
  6. Script error: No such module "citation/CS1".

Script error: No such module "Check for unknown parameters".

External links

Script error: No such module "Navbox".

  1. REDIRECT Template:Antiinfective-drug-stub

Template:Redirect category shell